{
  "data": {
    "indicator": {
      "slug": "approved-immunotherapy-drugs-multi-year-total",
      "name": "Approved immunotherapy drugs (multi-year total)",
      "definition": "Cumulative number of immunotherapy pharmaceutical products authorized for therapeutic use.",
      "unit": "count",
      "scale": "1",
      "default_unit": "count",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "count",
    "region": {
      "code": "US",
      "name": "United States",
      "type": "country"
    },
    "points": [
      {
        "period_start": "2010-01-01",
        "period_label": "2010–2025",
        "value": 30,
        "scale": "1",
        "unit": "count",
        "value_type": "actual",
        "statistic_id": "stat_MBM4FPC6Q63D53V4H7947N7R0N",
        "url": "https://statorigin.org/stat/stat_MBM4FPC6Q63D53V4H7947N7R0N",
        "source_org": "PhRMA",
        "source": {
          "org": "PhRMA",
          "org_short_name": "PhRMA",
          "document_title": "Research & Development",
          "document_url": "https://phrma.org/policy-issues/research-development",
          "locator": "Revolutionizing Cancer Care with Immunotherapy",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "US"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}